AVADEL PHARMACEUTICALS (AVDL) Stock Cash Flow
NASDAQ:AVDL - Nasdaq - IE00BDGMC594 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -26.41M | -48.83M | -160.28M | -137.46M | -77.33M | |||
| Depreciation Amortization | 2.96M | 2.68M | 1.77M | 1.49M | 815.00K | |||
| Income Taxes - Deferred | N/A | 0.00 | 0.00 | 26.02M | -15.67M | |||
| Change In Working Capital | -21.13M | -20.32M | -3.00M | 24.54M | 3.69M | |||
| Interest Paid | 8.34M | 7.18M | 5.25M | 9.66M | 6.47M | |||
| Taxes Paid | N/A | 0.00 | 0.00 | -29.06M | 76.00K | |||
| Other non cash items | 19.14M | 19.56M | 33.00M | 15.11M | 11.18M | |||
| OPERATING CASH FLOW | -25.43M | -46.91M | -128.51M | -70.30M | -77.31M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | 0.00 | -716.00K | -26.00K | |||
| Other Investing Activity | 42.71M | 51.78M | -50.09M | 80.41M | 56.95M | |||
| INVESTING CASH FLOW | 42.71M | 51.78M | -50.09M | 79.70M | 56.93M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | -38.66M | -8.65M | N/A | |||
| Stock Issued/Repurchased | 3.47M | 15.97M | 148.36M | 28.00M | 263.00K | |||
| Other Financing Activity | N/A | 0.00 | 25.64M | -4.80M | N/A | |||
| FINANCING CASH FLOW | 3.47M | 15.97M | 135.34M | 14.54M | 263.00K | |||
| Exchange Rate Effect | -169.00K | -639.00K | 455.00K | -664.00K | -896.00K | |||
| CHANGE IN CASH | 20.58M | 20.20M | -42.81M | 23.27M | -21.01M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -25.43M | -46.91M | -128.51M | -70.30M | -77.31M | |||
| Capital Expenditure | N/A | 0.00 | 0.00 | -716.00K | -26.00K | |||
| FREE CASH FLOW | -25.43M | -46.91M | -128.51M | -71.02M | -77.34M | |||
All data in USD